Molecular Therapy - Nucleic Acids

Slides:



Advertisements
Similar presentations
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Advertisements

Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide  Mostafa FN Abushahba,
Molecular Therapy - Nucleic Acids
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Molecular Therapy - Nucleic Acids
Léa L Lesueur, Lluis M Mir, Franck M André 
Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis  Y.-H. Li, G. Tavallaee,
Molecular Therapy - Nucleic Acids
209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.
Oligonucleotide Delivery to the Lung: Waiting to Inhale
Andrea L Kasinski, Frank J Slack  Molecular Therapy - Nucleic Acids 
Molecular Therapy - Nucleic Acids
Genome-editing Technologies for Gene and Cell Therapy
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis  Y.-H. Li, G. Tavallaee,
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 25, Issue 1, Pages 5-7 (January 2017)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Jan Hoinka, Phuong Dao, Teresa M Przytycka 
Léa L Lesueur, Lluis M Mir, Franck M André 
Molecular Therapy - Nucleic Acids
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection  Xinying Tang, Hongbo Zhang,
Microarray Gene Expression Analysis of Fixed Archival Tissue Permits Molecular Classification and Identification of Potential Therapeutic Targets in Diffuse.
Genome-editing Technologies for Gene and Cell Therapy
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy  Volume 20, (May 2012) DOI: /S (16)
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Erratum The American Journal of Human Genetics
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application  Graça Almeida-Porada, Anthony.
Molecular Therapy - Nucleic Acids
iRNA-PseU: Identifying RNA pseudouridine sites
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Molecular Therapy - Nucleic Acids
Fiona T van den Berg, John J Rossi, Patrick Arbuthnot, Marc S Weinberg 
372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.
Molecular Therapy - Nucleic Acids
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Polarized Fluorescence Resonance Energy Transfer Microscopy
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Thomas J Cradick, Peng Qiu, Ciaran M Lee, Eli J Fine, Gang Bao 
5′ Unlocked Nucleic Acid Modification Improves siRNA Targeting
Molecular Therapy - Nucleic Acids
Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.
Arati Sridharan, Chetan Patel, Jit Muthuswamy 
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Presentation transcript:

Molecular Therapy - Nucleic Acids Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments  Gyöngyi Munkácsy, Zsófia Sztupinszki, Péter Herman, Bence Bán, Zsófia Pénzváltó, Nóra Szarvas, Balázs Győrffy  Molecular Therapy - Nucleic Acids  Volume 5, (January 2016) DOI: 10.1038/mtna.2016.66 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Overview of the study and the studies evaluated. Flowchart of the database setup starting with a GEO search and ending up having 3,631 siRNA treatment-control pairs (a). The utilized statistical tests (b) start using these pairs. Characteristics of the utilized models and techniques across all studies (c). Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.66) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Heat map demonstrating gene silencing efficacy across all experiments. Columns include the silenced genes and the rows depict the expression for each gene (also ranked according to the order of the columns). Genes and experiments are ranked so that the diagonal green line resembles the silencing efficiency of the targeted gene across all comparisons'fluctuations in the remaining area correspond to noise and off-target effects of the silencing. Green equals lower expression in the siRNA treated sample compared with control. The line is not straight as some genes were silenced in multiple experiments and some experiment contained multiple genes. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.66) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Silencing effectiveness across all genes. A ranked order of all silenced genes based on fold change'values below 0 correspond to down-regulation, and values over 0 to up-regulation. All together 81.5% of measurements displayed a down-regulation below 0.7 and 30.5% were significant (red columns). Down-regulation was insufficient in 18.5% of studies, 6.3% even delivered an up-regulation instead of lower expression. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.66) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Correlation between study methods and silencing power. Selection of the cell line model had a marked effect on silencing efficiency (a), while utilization of different transfection methods or controls was not significant (b,c). There was no difference between cancer and noncancer studies (d). Protocols validating the silencing by Western-blot reached the highest reduction in the gene chip data as well (e). When comparing silencing for the same gene within independent experiments (n = 62 genes), only the cell line selection of had a significant effect (f). In each figure, lower fold change values correspond to better silencing efficiency. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.66) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions